{"created":"2023-05-15T14:36:02.068124+00:00","id":46376,"links":{},"metadata":{"_buckets":{"deposit":"ee3378f6-503d-4791-8fc3-876b77c40fdd"},"_deposit":{"created_by":1,"id":"46376","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"46376"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00046376","sets":["1"]},"author_link":["461981","461984","461982","461976","461987","461978","461989","461977","461985","461979","461980","461983","461988","461986"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-04","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"4","bibliographicPageEnd":"305","bibliographicPageStart":"296","bibliographicVolumeNumber":"19","bibliographic_titles":[{"bibliographic_title":"International Journal of Urology"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"BACKGROUND AND PURPOSE: To determine the efficacy and feasibility of carbon ion radiotherapy (C-ion RT) for prostate cancer.\n\\nPATIENTS AND METHODS: Between April 2000 and November 2003, 175 patients received C-ion RT using a recommended dose fractionation (66.0 GyE/20 fractions) established from prior studies. C-ion RT alone was performed for 33 patients constituting a low-risk group (Stage < or =T2a and PSA <20 ng/ml and Gleason score < or =6); the remaining 142 high-risk patients received an additional androgen deprivation therapy (ADT).\n\\nRESULTS: The 4-year overall survival and bNED rates were 91% and 87%, respectively. Local control was achieved in all but one patient. The 4-year bNED rates were 87% in the low-risk group and 88% in the high-risk group. In very advanced diseases (Stage > or= T3a or PSA > or= 20 ng/ml or Gleason score > or =8), there was significant difference in the bNED rate according to period of ADT administration (ADT > or =24 months: 93%, ADT <24 months: 73%, p<0.01). Grade 2 late toxicities developed in 4 patients (2%) for the rectum and 9 patients (5%) for the genitourinary system but no Grade 3 or higher toxicity was observed.\n\\nCONCLUSIONS: The effectiveness of C-ion RT for prostate cancer has been well confirmed. Based on these results, new study of a C-ion RT modified for the administration strategy of ADT according to the patient risk has been started by dividing patients into 3 groups, high-risk, intermediate-risk, and low-risk.","subitem_description_type":"Abstract"}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0919-8172","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Ishikawa, Hitoshi"}],"nameIdentifiers":[{"nameIdentifier":"461976","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tsuji, Hiroshi"}],"nameIdentifiers":[{"nameIdentifier":"461977","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kamada, Tadashi"}],"nameIdentifiers":[{"nameIdentifier":"461978","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Akakura, Kouichirou"}],"nameIdentifiers":[{"nameIdentifier":"461979","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Suzuki, Hiroyosi"}],"nameIdentifiers":[{"nameIdentifier":"461980","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Shimazaki, Jun"}],"nameIdentifiers":[{"nameIdentifier":"461981","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tsujii, Hirohiko"}],"nameIdentifiers":[{"nameIdentifier":"461982","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"石川 仁","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"461983","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"辻 比呂志","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"461984","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"鎌田 正","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"461985","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"赤倉 功一郎","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"461986","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"鈴木 啓悦","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"461987","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"島崎 淳","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"461988","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"辻井 博彦","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"461989","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Carbon-ion radiation therapy for prostate cancer","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Carbon-ion radiation therapy for prostate cancer"}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2012-08-09"},"publish_date":"2012-08-09","publish_status":"0","recid":"46376","relation_version_is_last":true,"title":["Carbon-ion radiation therapy for prostate cancer"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T23:52:34.625620+00:00"}